A Study of Carbon-14-Labeled LY2835219 ([^14C]-LY2835219) in Healthy Participants
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This type of study is called a radiolabeled study. For this study, LY2835219 (study drug) has
been specially prepared to contain radiolabeled carbon [^14C]. [^14C] is a naturally
occurring radioactive form of the element carbon. This study will help understand how the
drug appears in the blood, urine, and stool after it is administered.
In addition, this study will also evaluate the safety and tolerability of a single dose of
LY2835219 when given to healthy participants. Information about any side effects that may
occur will also be collected.
This study will last about 3 weeks for each participant, not including screening.